Arcellx (ACLX) Current Deferred Revenue (2021 - 2025)
Arcellx's (ACLX) quarterly Current Deferred Revenue came in at $109.1 million in Q4 2025, down 19.24% year-on-year from $135.1 million in Q4 2024, and up 82.54% quarter-over-quarter from $59.8 million in Q3 2025.
Arcellx (ACLX) Current Deferred Revenue (2021 - 2025) Analysis & Trends
Arcellx's Current Deferred Revenue history runs 4 years deep, the most recent figure standing at $109.1 million for Q4 2025.
- On a quarterly basis, Current Deferred Revenue fell 19.24% year-over-year to $109.1 million in Q4 2025; TTM through Dec 2025 was $109.1 million, a 19.24% decrease from a year earlier, with the FY2025 full-year figure at $109.1 million, down 19.24% from the prior year.
- Current Deferred Revenue grew to $109.1 million in Q4 2025 per ACLX's latest filing, from $59.8 million in the prior quarter.
- Across five years, Current Deferred Revenue topped out at $221.2 million in Q4 2023 and bottomed at $183000.0 in Q4 2021.
- The 4-year median for Current Deferred Revenue is $69.9 million (2024), against an average of $81.0 million.
- Across the five-year window, Current Deferred Revenue sank 84.05% in 2024 and surged 296.27% in 2025, its largest moves.
- Year by year, Current Deferred Revenue stood at $183000.0 in 2021, then soared by 120777.6% to $221.2 million in 2023, then sank by 38.95% to $135.1 million in 2024, then retreated by 19.24% to $109.1 million in 2025.
- Per Business Quant, the three latest ACLX Current Deferred Revenue figures stand at $109.1 million (Q4 2025), $59.8 million (Q3 2025), and $59.3 million (Q2 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - |
| 10 | Arcellx | 6.48 Bn | 6.48 Bn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 109.07 Mn |
| Sep 30, 2025 | 59.75 Mn |
| Jun 30, 2025 | 59.32 Mn |
| Mar 31, 2025 | 57.37 Mn |
| Dec 31, 2024 | 135.05 Mn |
| Sep 30, 2024 | 69.87 Mn |
| Jun 30, 2024 | 14.97 Mn |
| Mar 31, 2024 | 31.19 Mn |
| Dec 31, 2023 | 221.21 Mn |
| Sep 30, 2023 | 94.18 Mn |
| Jun 30, 2023 | 93.88 Mn |
| Mar 31, 2023 | 107.29 Mn |
| Dec 31, 2021 | 183,000.00 |